RISO-KAGAKU-CORPORATION
RISO KAGAKU CORPORATION (President & CEO: Akira Hayama; hereinafter “RISO”) announced today the launch of VALEZUS, a new brand of high-speed ink-jet printers for the production-printing market. RISO will start with successive rollouts worldwide of the new brand’s first product, the VALEZUS T2100, a high-speed, 320-page-per-minute (320-ppm) cut-sheet printer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190818005001/en/
One of RISO’s commanding strengths is the development of inks optimized for high-speed paper feeding and high-speed printing. This expertise enables RISO to deliver unique printing solutions serving the demand for high-volume printing. With technologies developed and cultivated in this field, RISO launches the VALEZUS, a fresh brand targeting the production-printing market.
2 The all-new VALEZUS T2100
VALEZUS T2100
The first product of the new brand, the VALEZUS T2100 is a high-speed full-color cut-sheet inkjet printer. By connecting printer engines to print the front and back-side respectively, the VALEZUS T2100 achieves a blazing-fast double-sided printing speed of 320ppm. The VALEZUS T2100 offers a compact footprint for a production printer as well as superior ease of use and maintenance.
With these features, the VALEZUS T2100 increases productivity and dramatically improves work efficiency in high-volume printing.
In high-volume printing applications, such as transactional printing at print service providers, in-house printing at financial institutions, insurance companies and government offices, the VALEZUS T2100 opens a world of new possibilities in cut-sheet printing.
RISO will show the VALEZUS T2100 at the following exhibitions:
“The Print Show 2019” from September 17 to 19 in Birmingham, United Kingdom.
“PRINTING United 2019” from October 23 to 25 in Dallas, Texas, United States.
You can view a 1-minute promotional video about this product here. https://youtu.be/bpzQLYe1Z54
Product name and launch period
Product name |
VALEZUS T2100 |
Launch period |
Fall 2019 |
Rollout will begin in North America and Europe. Launch dates in Japan and elsewhere in Asia are to be determined.
Main features of the VALEZUS T2100
High Productivity
1) Capable of 320ppm high speed cut sheet printing
The VALEZUS T2100 can print 320ppm*1 or 19,200 pages per hour*2 , based on full-color, double-sided printing of A4-sized paper. Because the VALEZUS T2100 is a cut sheet printer, it can easily handle short-run jobs as well, enabling speedy processing of a diverse range of jobs.
*1 Continuous printing of A4-sized paper with long-edge feed on standard settings
*2 Not including cleaning time
2) Incorporation of newly developed high-capacity feeder/stacker units that enable paper loading/unloading during continuous printing
The VALEZUS T2100 is equipped with two high-capacity feeder/stacker units, each capable of feeding and stacking up to 4,000 sheets (total of 8,000 sheets). The two units can be switched while the printer is active, allowing users to load/unload paper without stopping the job. Also, the stacker unit is equipped with a jogger mechanism and dedicated cart, enabling smooth transition to post-processing after printing.
* The feeder/stacker units are scheduled to be available in the spring of 2020.
3) Compatible with PDF, PostScript® as well as AFP/IPDS
The VALEZUS T2100 can fit in existing workflow of customers. It supports PDF and Postscript, generally used in an open system environment as well as AFP/IPDS, which is used as an industry standard for mission-critical production print applications.
4) Oil-based ink complements environmentally-conscious printing by low energy consumption
The VALEZUS T2100 incorporates an inkjet system that adopts oil-based inks ensuring energy-saving operation. Oil-based inks contribute to energy-saving because there is no need for ink-drying heaters required for water-based inks, and unlike toner-based technologies, there is no heat-fixing process required.
Specifications
ITEM |
Description |
|
Print Type |
Line-type inkjet system (drop on-demand) |
|
Ink Type |
Oil-based pigment ink (Cyan, Magenta, Yellow, Black, Gray) |
|
Print Speed *1 |
Duplex: 320 ppm, Simplex: 160 ppm (A4 LEF, Letter LEF) |
|
Resolution |
Standard |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 300dpi |
Fine |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 600dpi |
|
Paper Size |
Double Tray Feeder |
Max: 330.2mm x 465mm (13” x 18.3”) Min: 148mm x 210mm (5.9” x 8.3”) |
Feed Tray |
Max: 297mm x 432mm (11.6” x 17.0”) Min: 182mm x 210mm (7.2” x 8.3”) |
|
Paper Weight |
Double Tray Feeder |
46gsm to 210gsm (12-lb bond to 56-lb bond) |
Feed Tray |
52gsm to 104gsm (14-lb bond to 28-lb bond) |
|
Paper Tray Capacity |
Double Tray Feeder |
4,000 sheets x 2 trays*2 (Height up to 440mm [17.3”]) |
Feed Tray |
500 sheets x 3 trays*2 (Height up to 56mm [2.2”]) |
|
Output Tray Capacity |
Double Tray Stacker |
4,000 sheets x 2 trays *2 *3 (Height up to 440mm [17.3”]) |
Power Consumption |
Max. 3,010W |
|
Dimensions (W x D x H) |
4,755mm x 750mm x 1,445mm (187.2” x 29.6” x 56.9”) |
|
*1 When using plain paper and recycled paper (85 gsm [23-lb bond]), and standard density setting.
*2 When using plain paper and recycled paper (85 gsm [23-lb bond]).
*3 When short edge is less than 182mm or long edge is less than 257mm, Max capacity is 1,000 sheets.
Specifications are subject to change without notice.
Symbol mark, logo mark and VALEZUS are trademarks or registered trademarks of RISO KAGAKU CORPORATION. Adobe and PostScript are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries. Other corporate names and/or trademarks are either registered trademarks or trademarks of each company, respectively.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190818005001/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma17.11.2025 12:00:00 CET | Press release
ZIIHERAplus TEVIMBRA and chemotherapy demonstrated clinically meaningful and statistically significant improvements in PFS and OS versus trastuzumab and chemotherapyZIIHERA plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first interim analysisFirst Phase 3 trial in 15 years to demonstrate a clinical benefit in this patient population with a novel HER2-targeted therapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with or without PD-1 inhibitor TEVIMBRA® (tislelizumab), as first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcin
BoConcept, Lego, Lurpak, and Pandora are among the Honoured Winners of the 2025-2026 World Branding Awards in Osaka17.11.2025 11:48:00 CET | Press release
The 20th World Branding Awards celebrated the success and achievements of leading brands across National, Regional, and Global categories. In the 2025–2026 edition, over 1,092 brands from 66 countries were nominated as “Brand of the Year”. From this distinguished selection, fewer than 100 brands emerged as winners, representing the highest standards of excellence across the three tiers of recognition. The World Branding Awards Ceremony stepped outside London for the first time, bringing its global presence to the Osaka City Museum of Fine Arts. Over 80 international guests joined the celebration, hosted by Allie Sakakibara and enriched by a keynote from Miho Noguchi on immersive brand experiences. Honoured as Global winners in branding across diverse industries were Cadbury (USA), IKEA (Sweden), Marriott International (United Kingdom), Nike (USA), Sennheiser (Germany), and Yakult (Japan). Winners from Denmark include BoConcept, Lego, Lurpak, and Pandora.Other National tier winners incl
Global Winners of the 2025–2026 World Branding Awards Announced at First-Ever Japan Ceremony17.11.2025 11:43:00 CET | Press release
Now in its 20th edition, the World Branding Awards continues to spotlight the world’s most impactful and trusted brands. This year, over 1,092 brands from 66 countries were nominated as “Brand of the Year”, with less than 100 declared Winners across Global, Regional, and National tiers. The World Branding Awards Ceremony stepped outside London for the first time, bringing its global presence to the Osaka City Museum of Fine Arts. The 2025–2026 edition welcomed over 80 international guests and was presented by the acclaimed Allie Sakakibara. The evening was further elevated by a keynote presentation from Miho Noguchi, who shared insights on building emotional resonance through immersive brand experiences. Global Tier winners celebrated their outstanding branding excellence across various industries, including IKEA (Sweden), Lurpak (Denmark), Marriott International (United Kingdom), Nike (USA), Sennheiser (Germany), and Yakult (Japan). These brands consistently demonstrated strength, inf
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US17.11.2025 11:30:00 CET | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product.1 POHERDY is the first and only approved pertuzumab biosimilar in the US, representing an important milestone in expanding access to quality and potentially more affordable biologic therapies for patients with certain HER2-positive breast cancers.2 "Expanding access to treatments for diseases that disproportionately impact women, including breast cancer, the most common cancer among women in the US excluding skin cancer, is at the core of our mission,” said Jon Martin, US Commercial Lead, Biosimilars and Established Brands at Organon.3 “Not only is POHERDY the first approved biosimilar to PERJETA in the US, but its approval also builds
WEX® Unlocks Access to 20,000+ Tesla Superchargers Across Europe17.11.2025 11:15:00 CET | Press release
EV drivers of any car brand using the EV Driver by WEX app can now charge at one of Europe’s largest and most reliable charging networks, benefitting from low-cost fast charging across 1,500+ locations. WEX® (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced integration with the Tesla Supercharger network, adding over 20,000 fast-charging points across 1,500+ locations to its platform. The move significantly expands charging options for WEX’s customers, particularly in areas where high-power charging has been limited or expensive. By bringing Tesla Superchargers into their ecosystem, WEX gives drivers access to competitively priced fast charging with speeds up to 250 kW, increasing availability of high-power charging stations by 10%. WEX customers already use the EV Driver by WEX app to charge at over 1 million charging points throughout Europe. Now, they can access Tesla Superchargers with the same seamless experience: compari
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
